ANTI-USTEKINUMAB ANTIBODIES USING A DRUG TOLERANT ASSAY IS THE ONLY PREDICTIVE FACTOR OF CLINICAL REMISSION IN INFLAMMATORY BOWEL DISEASE PATIENT UNDER USTEKINUMAB
Narjous CHAWKI 1
Mohammad CHAWKI 2
Pierre Cixous 2
Pauline Veyrard 2
Anne Berger 2
Jean Marc Phelip 3
Stéphane Paul 3
Xavier Roblin 3
1 Hopital Nord, Saint-Priest-en-Jarez, France
2 AlphaBeta, Stains, France
3 University of St. Etienne, Saint Etienne, France
Session
IBD (Posters)
Conference
UEG Week Virtual 2020
Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]